Algo version: 0.98b
Haemonetics Corp is listed at the NYSE Exchange
Haemonetics Corp [HAE]
NYSE Sector: Healthcare Industry:Medical - Instruments & Supplies

Is Haemonetics Corp stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Haemonetics Corp 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was $121.08, you would have made a loss of $-47.84 per share or -39.51%

Yes, the average daily trading liquidity for Haemonetics Corp is $575 662 thousand. You should therefore be able to get in and out of your positions relatively fast.

Haemonetics Corp has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.22, the company's ability to pay off the debt is normal. Haemonetics Corp has a good net profit margin of 8.98% and should have high tolerances against inflation.

We have calculated the inflation risk for Haemonetics Corp to be low [0.4 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.